Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin and Gemcitabine in Advanced Pancreatic Cancer
NCT00944463Phase 2Completed
- Sponsor
- Samsung Medical Center
- Start
- Oct 2008
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of simvastatin in pancreatic adenocarcinoma (PDAC), sponsored by Samsung Medical Center. Started Oct 2008; status: completed.
02
Drugs
simvastatin
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00944463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00944463.